Optimization of gatifloxacin liposomal hydrogel for enhanced transcorneal permeation

Journal of Liposome Research

Volumn 20, Issue 1, 2010, Pages 31-37

  Hosny, Khaled Mohamed ^a,b  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b Beni Suef University   (Egypt)

Author keywords

Gatifloxacin; Hydrogel; Liposome; Ocular drug delivery system; Transcorneal permeation

Indexed keywords

CARBOPOL 940; CHOLESTEROL; DICETYL PHOSPHATE; GATIFLOXACIN; LIPOSOME; OCTADECYLAMINE; PHOSPHATIDYLCHOLINE; AMINE; HYDROGEL; QUINOLONE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CORNEA; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; HYDROGEL; IN VITRO STUDY; MOLAR TOOTH; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BIOAVAILABILITY; CHEMISTRY; EYE; MEDICINAL CHEMISTRY; RABBIT; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; AMINES; ANIMALS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CHOLESTEROL; EYE; FLUOROQUINOLONES; HYDROGEL; LIPOSOMES; PHOSPHATIDYLCHOLINES; RABBITS;

EID: 77149170070     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982100903030255     Document Type: Article

References (42)

1. Adenis, J.P., Colin, J., Verin, P., Saint-Blancat, P., Malet, F. (1995). Ciprofloxacin ophthalmic solution versus rifamycin ophthalmic solution for the treatment of conjunctivitis and blepharitis. Eur J Ophthalmol 5:82-87.
2. Aranda, F.J., Teruel, J.A., Ortiz, A. (2005). Further aspects on the hemolytic activity of the antibiotic lipopeptide Iturin A. Biochim Biophys Acta 1713:51-56.
3. Bangham, A.D., Standish, M.M., Watkins, J.C. (1965). Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13:238-252.
4. Budai, L., Hajdu, M., Budai, M., Grof, P., Beni, S., Noszal, B., et al. (2007). Gels and liposomes in optimized ocular drug delivery: studies on ciprofloxacin formulations. Int J Pharm 343:34-40.
5. Chaudhry, N.A., Flynn, H.W., Murray, T.G., Tabandeh, H., Mello, M.O., Miller, D. (1999). Emerging ciprofloxacin resistant Pseudomonas aeruginosa. Am J Ophthalmol 128:509-510.
6. Choudhari, K.B., Labhasetwar, V., Dorle, A.K. (1994). Liposomes as a carrier for oral administration of insulin: effect of formulation factors. J Microencapsul 11:319-325.
7. Cochereau-Massin, I., Bauchet, J., Marrakchi-Benjaafar, S., Saleh-Mghir, A., Faurisson, F., Vallois, J.M., et al. (1993). Efficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitis. Antimicrob Agents Chemother 37:633-636.
8. Deepika, A., Indu, P.K. (2005). Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system. Int J Pharm 290:155-159.
9. Diamond, J.P., White, L., Leeming, J.P., Bing Hoh, H., Easty, D.L. (1995). Topical 0.3% ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial keratitis: a new method for comparative evaluation of ocular drug penetration. Br J Ophthalmol 79:606-609.
10. du Plessis, J., Ramachandran, C., Weiner, N., Muller, D.G. (1996). The influence of lipid composition and lamellarity of liposomes on the physical stability of liposomes upon storage. Int J Pharm 127:273-278.
11. Durrani, A.M., Davies, N.M., Thomas, M., Kellaway, I.W. (1992). Pilocarpine bioavailability from a mucoadhesive liposomal ophthalmic drug delivery system. Int J Pharm 88:409-415.
12. El-Samaligy, M.S., Nagia, N.N., Mahmoud, E.A. (2006). Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation. Int J Pharm 308:140-148.
13. Farkas, E., Schubert, R., Zelḱo, R. (2004). Effect of beta-sitosterol on the characteristics of vesicular gels containing chlorhexidine. Int J Pharm 278:63-70.
14. Foradada, M., Estelrich, J. (1995). Encapsulation of thioguanine in liposomes. Int J Pharm 124:261-269.
15. Galovic Rengel, R., Barisic, K., Pavelic, Z., Zanic Grubisic, T., Cepelak, I., Filipovic-Grcic, J. (2002). High-efficiency entrapment of superoxide dismutase into mucoadhesive chitosancoated liposomes. Eur J Pharm Sci 15:441-448.
16. Garg, P., Sharma, S., Rao, G.N. (1999). Ciprofloxacin-resistant Pseudomonas keratitis. Ophthalmology 106:1319-1323.
17. Gregoriadis, G., Florence, A.T. (1993). Liposomes in drug delivery: clinical, diagnostic, and ophthalmic potential. Drugs 45:15-28.
18. Gross, R.D., Hoffman, R.O., Lindsay, R.N. (1997). A comparison of ciprofloxacin and tobramycin in bacterial conjunctivitis in children. Clin Pediatr (Phila) 36:435-444.
19. Gruner, S.M. (1997). Materials properties of liposomal bilayers. In: Ostro, M.J. (Ed.), Liposomes from Biophysics to Therapeutics (pp 1-38). New York: Marcel Dekker.
20. Gulati, M., Grover, M., Singh, M., Singh, S. (1998). Study of azathioprine encapsulation into liposomes. J Microencapsul 15: 485-494.
21. Jauch, A., Fsadni, M., Gamba, G. (1999). Meta-analysis of six clinical phase III studies comparing lomefloxacin 0.3% eye drops twice-daily to five standard antibiotics in patients with acute bacterial conjunctivitis. Graefe's Arch Clin Exp Ophthalmol 237:705-713.
22. Jensen, H., Zerouala, C., Carrier, M., Short, B. (2005). Comparison of ophthalmic gatifloxacin 0.3% and ciprofloxacin 0.3% in healing of corneal ulcers associated with Pseudomonas aeruginosa- induced ulcerative keratitis in rabbits. J Ocul Pharmacol Ther 21:36-43.
23. Karathanasis, E., Ayyagari, A.L., Bhavane, R., Bellamkonda, R.V., Annapragada, A.V. (2005). Preparation of in vivo cleavable agglomerated liposomes suitable for modulated pulmonary drug delivery. J Contr Rel 103:159-175.
24. Kaur, I.P., Garg, A., Singla, A.K., Aggarwal, D. (2004). Vesicular systems in ocular drug delivery: an overview. Int J Pharm 269:1-14.
25. Kaur, I.P., Smitha, R. (2002). Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery. Drug Dev Ind Pharm 28:353-369.
26. Law, S.L., Hung, H.Y. (1998). Properties of acyclovir-containing liposomes for potential ocular delivery. Int J Pharm 161:253-259.
27. Le, Bourlais CL, Acar, L., Zia, H., Sado, P.A., Needham, T., Leverge, R. (1998). Ophthalmic drug delivery systems-recent advances. Prog Retin Eye Res 17:35-58.
28. Lee, V.H., Urrea, P.T., Smith, R.E., Schazlin, D. (1985). Therapeutic review: ocular drug bioavailability from topically applied liposomes. Surv Ophthalmol 29:335-348.
29. Lin, H.H., Ko, S.-M., Hsu, L.R., Tsai, Y.H. (1996). The preparation of norfloxacinloaded liposomes and their in-vitro evaluation in pig's eye. J Pharm Pharmacol 48:801-805.
30. Malhotra, M., Majumdar, D.K. (1997). In vitro transcorneal permeation of ketorolac tromethamine from buffered and unbuffered aqueous ocular drops. Ind J Exp Biol 35:941-947. (Pubitemid 27446120)
31. Nagarsenker, M.S., Londhe, V.Y., Nadkarni, G.D. (1999). Preparation and evaluation of liposomal formulations of tropicamide for ocular delivery. Int J Pharm 190:63-71.
32. New, RRC. (1990). Liposomes: A Practical Approach. Oxford, UK: Oxford University Press.
33. Nii, T., Ishii, F. (2005). Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method. Int J Pharm 298:198-205.
34. Perry, C.M., Ormrod, D., Hust, M., Susan, V.O. (2002). Gatifloxacin: a review of its use in the management of bacterial infections. Drugs 62:169-207.
35. Perugini, P., Pavanetto, F. (1998). Liposomes containing boronophenylalanine for boron neutron capture therapy. J Microencapsul 15:473-483.
36. Rania, M.H., Samar, M., Nahed, D.M., Ahmed, S.G. (2007). Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS Pharm Sci Tech 8:1-12.
37. Schaeffer, H.E., Krohn, D.L. (1982). Liposomes in topical drug delivery. Invest Ophthalmol Vis Sci 22:220-227.
38. Singh, K., Mezei, M. (1983). Liposomal ophthalmic drug delivery system. I. Triamcinolone acetonide. Int J Pharm 16:339-344.
39. Srinath, P., Vyas, S.P., Prakash, V.D. (2000). Preparation and pharmacodynamic evaluation of liposomes of indomethacin. Drug Dev Ind Pharm 26:313-321.
40. Sultana, J., Jain, R., Agil, M., Ali, A. (2006). Review of ocular drug delivery. Curr Drug Deliv 3:207-217.
41. Szoka, F., Papahodjopoulos, D. (1978). Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci U S A 75:4194-4198.
42. Wiechens, B., Neumann, D., Grammer, J.B., Pleyer, U., Hedderich, J., Duncker, G.I. (1998-1999). Retinal toxicity of liposome-incorporated and free ofloxacin after intravitreal injection in rabbit eyes. Int Ophthalmol 22:133-143.